 - Is a male patient with histologically proven adenocarcinoma of the prostate all stages in whom endocrine treatment is indicated, except for neoadjuvant hormonal therapy. For patients, prostate-specific antigen PSA increases on two consecutive determinations at least 2 weeks apart prior to Visit 1 must be documented. 